semaglutide cardiovascular outcomes trial (CVOT) Effects of Semaglutide on Heart

Unique role of junctional adhesion moleculea in maintaining mucosal homeostasis in inflammatory bowel disease

More recently, the approval of the first oral GLP-1 analog, semaglutide (Rybelsus), for type 2 diabetes represents a major step forward in addressing one of the key challenges in this field: patient compliance associated with subcutaneous injections

Mounjaro is associated with type 2 diabetes treatment, while Zepbound has approved weight-management indications for eligible patients

The time scales differ because one involves biosynthesis of new pigment proteins and the other involves neurotransmitter signalling in existing brain circuits

Stick to a routine

Check for large air bubbles